SYDNEY, Australia, April 26 /PRNewswire-FirstCall/ -- Australian drug
development company Alchemia Limited (ASX: ACL) today announced the
appointment of Dr Reddy's Laboratories Limited (NYSE: RDY) as its marketing
partner for synthetic heparin (fondaparinux sodium).
